Study start-up & site activation consulting

Make the path to site activation visible before it becomes late.

Merindale works with research teams to turn feasibility assumptions, startup dependencies, contracts, budgets, regulatory work, training, and internal handoffs into one practical readiness path.

The problem

“Almost ready” is not a startup status.

Study start-up often slows because the work is spread across several teams that each see only part of the critical path. A budget is moving, regulatory documents are nearly complete, pharmacy is waiting on one item, system access is not finished, and everyone is reasonably busy—but nobody can see what actually determines the activation date.

Merindale helps the team make that path visible. We start with the institution's real process, identify the dependencies that can and cannot run in parallel, clarify ownership, and build an operating rhythm around the work that remains.

This is site-side consulting. It is designed to complement—not replace—the sponsor, CRO, IRB, contracting, regulatory, pharmacy, finance, and institutional teams already responsible for their parts of startup.

What we review

The startup path from feasibility to green light.

The exact scope depends on the site and study. We focus on the parts of startup that the research program can influence or coordinate.

01

Feasibility assumptions

Patient fit, investigator availability, staffing, competing studies, special procedures, systems, and the conditions behind the decision to take the study.

02

Critical-path dependencies

Contracts, budgets, coverage analysis where applicable, IRB/regulatory work, essential documents, pharmacy, lab, system builds, access, training, and internal approvals.

03

Ownership & handoffs

Who owns each next action, how work moves between teams, what signals readiness, and where items spend time waiting for the next owner.

04

Readiness & escalation

One view of open prerequisites, aging, blockers, decisions needed, and the escalation rhythm required to keep startup moving.

A typical engagement

Start with one delayed study—or one startup process that keeps repeating the same delay.

Diagnose: review the current startup path, status trackers, feasibility assumptions, handoffs, open dependencies, and recent activation history where available.

Redesign: work with the responsible teams to simplify status visibility, define ownership, identify parallel work, and create a practical critical-path view.

Transfer: leave a readiness model, operating cadence, measures, and documentation the internal team can continue using.

Typical outputs may include a feasibility decision framework, dependency map, activation tracker, readiness checklist, aging view, escalation path, and role ownership model.

Experience behind the service

Built from site-side startup work, not a generic project-management template.

The service is informed by documented site-side experience in feasibility, study start-up and activation, budgets and invoicing, contracts and MTAs, sponsor/CRO coordination, essential-document oversight, staff leadership, and prior activation-process improvement work.

Research institutions

When several internal functions own parts of startup and leadership needs a clearer cross-functional view.

Site networks

When startup processes vary across sites or repeatable bottlenecks need to be made visible.

Research sites

When a small team needs a practical activation system without adding unnecessary administrative overhead.

Sponsor/CRO partners

When the question is specifically about site-side readiness, handoffs, or activation friction.

Related guidance

Better startup begins before the startup tracker.

Our clinical trial site feasibility guide covers ten questions to answer before committing site capacity.

Our site workflow handoffs guide explains why work often slows after one function finishes and before the next owner begins.

For the broader service portfolio, return to Clinical Trial Site Operations Consulting Services.

Is activation slipping without one obvious blocker?

Bring the study, the current status, and the parts of the startup process that feel hardest to control. We will start by deciding whether the problem fits our site-side experience.